Search by Drug Name or NDC
NDC 50804-0395-01 Epsom Salt 1 g/g Details
Epsom Salt 1 g/g
Epsom Salt is a ORAL; TOPICAL GRANULE in the HUMAN OTC DRUG category. It is labeled and distributed by Good Sense (Geiss, Destin & Dunn, Inc.). The primary component is MAGNESIUM SULFATE, UNSPECIFIED.
Product Information
| NDC | 50804-0395 |
|---|---|
| Product ID | 50804-395_f28c080b-866a-4951-870f-6158b4e6b93d |
| Associated GPIs | 46100030102750 |
| GCN Sequence Number | 003022 |
| GCN Sequence Number Description | magnesium sulfate GRANULES 495 MG/5 G ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 09200 |
| HICL Sequence Number | 001327 |
| HICL Sequence Number Description | MAGNESIUM SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Epsom Salt |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Epsom Salt |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | GRANULE |
| Route | ORAL; TOPICAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/g |
| Substance Name | MAGNESIUM SULFATE, UNSPECIFIED |
| Labeler Name | Good Sense (Geiss, Destin & Dunn, Inc.) |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50804-0395-01 (50804039501)
| NDC Package Code | 50804-395-01 |
|---|---|
| Billing NDC | 50804039501 |
| Package | 454 g in 1 POUCH (50804-395-01) |
| Marketing Start Date | 2017-12-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |